Chemplast Sanmar Limited has informed the Exchange about Transcript
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemplast Sanmar reported FY25 revenue of INR4,346 crores, up 11% YoY, with EBITDA jumping sharply from INR26 crores to INR219 crores, though the company remained in a net loss of INR110 crores. Q4 FY25 revenue grew 10% YoY to INR1,151 crores with EBITDA of INR37 crores. The Specialty Chemicals segment, including Custom Manufactured Chemicals (CMC) and Paste PVC, was the key growth driver, with CMC crossing INR500 crores on over 80% YoY growth. Management announced a new INR340 crore Greenfield R32 refrigerant project, targeted for completion by October 2026, alongside expansion plans at the Cuddalore Paste PVC plant. Net debt stood at INR1,117 crores with a comfortable cash position of INR700 crores, and CRISIL downgraded long-term ratings to A+ (stable) from AA-. Management is hopeful anti-dumping duties on suspension PVC and BIS standards implementation by June 2025 will revive the PVC business in H2 FY26.
Positive signals for shareholders — significant EBITDA improvement, PBT positivity in CMC business, and a clear growth roadmap in specialty chemicals including the R32 foray. However, continued losses, high net debt, rating downgrade, and dependence on anti-dumping outcomes for PVC recovery remain near-term concerns. The stock reaction may hinge on progress of trade remedy measures and execution of the R32 project.